David Marberger
About David S. Marberger
Executive Vice President and Chief Financial Officer of Conagra Brands (CAG) since 2016, Marberger oversees Finance, Investor Relations, Information Technology, and M&A; he has prior public company CFO experience and 30+ years of finance leadership (proxy does not enumerate prior employers) . In FY2025, Conagra’s net sales were $11.6B and operating profit $1.4B with free cash flow of $1.3B, while the company reduced net debt; TSR (indexed $100) measured 78.60 at FY2025 year-end, reflecting recent share underperformance versus earlier years . YoY, reported net sales declined from $12.051B to $11.613B (≈-3.6%), and Adjusted Operating Profit declined from $1.923B to $1.636B (≈-14.9%), while Adjusted Free Cash Flow was $1.159B, all metrics used for incentive pay calibration .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Conagra Brands | EVP & CFO | 2016–present | Leads Finance, IR, IT, and M&A; principal financial officer |
External Roles
- None disclosed in the proxy for Marberger (no public company directorships listed) .
Fixed Compensation
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Base Salary ($) | 760,646 | 798,077 | 830,385 |
| All Other Compensation ($) | 137,866 | 155,174 | 171,014 |
| AIP Target as % of Eligible Earnings | 100% | 100% | 100% |
Notes: FY2025 base salary rate set at $835,000 (+3.7% vs FY2024) .
Performance Compensation
Annual Incentive Plan (AIP) – Structure and FY2025 Outcomes (Company-level)
| Metric (weight) | Target | Actual (Adj) | Payout Factor |
|---|---|---|---|
| Adjusted Operating Profit (50%) | $1,893M | $1,636M | 33.4% |
| Adjusted Net Sales (25%) | $12,084M | $11,650M | 54.6% |
| Adjusted Free Cash Flow (25%) | $1,001M | $1,159M | 176.0% |
| Calculated Payout | — | — | 74.3% |
Marberger’s FY2025 AIP payout was $616,976 (company payout 74.3% and individual modifier 100%) .
Long-Term Incentives (LTI) – Design and Grants
- Design: 60% Performance Shares (Adjusted EPS 70%, Adjusted Net Sales 30%; FY2025 grants include a ±10% relative TSR modifier vs near-in peer group), 40% RSUs; max 200% of target .
- FY2025 LTI grants (grant date Jul 24, 2024): 34,257 RSUs (service-based), 51,386 Performance Shares (target); total target LTI value $2,500,000 .
- Vesting: RSUs granted on/after Jul 19, 2023 vest ratably 1/3 per year over 3 years; earlier RSUs generally cliff vest at 3 years; retention RSUs (FY2024 grant) cliff vest at 3 years .
- FY2023–FY2025 Performance Share cycle earned at 70.1% of target (company-wide) .
LTI Grants and Payouts (Marberger)
| Item | Detail |
|---|---|
| FY2025 RSU grant | 34,257 units (grant date 7/24/2024); fair value $932,133 |
| FY2025 Performance Shares (target) | 51,386 units (grant date 7/24/2024); fair value $1,534,386 |
| FY2024 Retention Grant (context) | $2.5M total; 60% PS (FY2024–FY2026) tied to EPS/Net Sales; 40% RSUs cliff vest at 3 years (grant date 7/19/2023) |
| FY2023–FY2025 PS payout | 70.1% of target (company cycle result) |
Equity Ownership & Alignment
Beneficial Ownership and Guidelines
| Item | Value |
|---|---|
| Shares owned (7/23/2025) | 293,041 |
| Right to acquire within 60 days (options/RSUs) | 80,667 |
| Ownership as % of outstanding | ~0.06% (293,041 / 478,693,731) |
| Stock ownership guideline | 4x salary; Marberger actual ~10x as of 7/23/2025 |
| Pledging / Hedging | Prohibited for directors and senior executives |
Outstanding Awards at FY2025 Year-End (selected)
| Award Type | Grant Date | Unvested/Unearned (#) | Market Value ($) |
|---|---|---|---|
| RSUs (annual) | 7/20/2022 | 46,251 | 1,036,022 |
| RSUs (annual) | 7/19/2023 | 20,211 | 452,726 |
| RSUs (retention) | 7/19/2023 | 30,316 | 679,078 |
| RSUs (annual) | 7/24/2024 | 34,257 | 767,357 |
| Performance Shares (FY2023–FY2025) | N/A | 49,545 (target) | 1,109,805 |
| Performance Shares (FY2024–FY2026) | N/A | 49,545 (target) | 1,109,805 |
| Performance Shares (FY2025–FY2027) | N/A | 53,348 (target) | 1,195,003 |
| Stock Options (exercisable) | 9/1/2016 | 69,248 @ $34.26, exp. 8/31/2026 | — |
Notes: Market values use $22.40 (closing price on last FY trading day) . RSU vesting terms as noted above . Dividend equivalents accrue on earned Performance Shares .
Nonqualified Deferred Compensation
| Item | Exec Contributions (FY2025) | Company Contributions (FY2025) | Earnings (FY2025) | Balance at FY-End |
|---|---|---|---|---|
| Voluntary Deferred Comp Plan | $65,576 | $134,116 | $58,629 | $2,358,378 |
Employment Terms
- Severance Plan: For NEOs other than CEO, guideline is 52 weeks’ salary continuation plus one additional week per year of service; AIP prorated based on actual results; equity generally vests pro rata or continues per award terms; medical benefits per plan .
- Change-of-Control (CoC): Double-trigger equity vesting is generally required; program covers senior executives; CoC defined via board/ownership/control transactions; no excise tax gross-ups since FY2012 .
- Clawback: Policy refreshed in FY2024 to mandate recoupment upon restatements and allow discretionary recoupment in specified circumstances .
Quantified Termination/CoC Economics (Marberger)
| Scenario (as of FY2025) | Severance/Salary ($) | AIP ($) | RSUs ($) | PS ($) | Benefits/Other ($) | Total ($) |
|---|---|---|---|---|---|---|
| Involuntary without Cause | 963,462 | 616,976 | 2,674,954 | 2,251,581 | 27,543 | 6,534,516 |
| CoC + Involuntary w/o Cause or Good Reason | 1,670,000 (lump sum salary) | 2,106,684 | 2,935,184 | 5,555,805 | 217,332 | 12,490,005 |
Notes: Composition of “Benefits/Other” includes benefits continuation, outplacement, and qualified/nonqualified plan amounts per table .
Performance & Track Record
| Indicator | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Conagra TSR (value of $100) | 110.86 | 100.95 | 78.60 |
| Adjusted EPS ($) | 2.77 (for FY21–23 PSP) | 2.67 (for FY22–24 PSP) | 2.02 (for FY23–25 PSP) |
| Net Sales ($B, reported) | 12.277 | 12.051 | 11.613 |
| Adjusted Operating Profit ($B) | 1.917 | 1.923 | 1.636 |
| Free Cash Flow (Adj) ($B) | — | — | 1.159 |
AIP payouts tied to FY2025 company performance paid at 74.3% of target; FY2023–FY2025 performance shares earned at 70.1% of target, evidencing pay-for-performance linkage .
Say‑on‑Pay & Shareholder Feedback
- 2024 Say‑on‑Pay received ~45% support; in response, Conagra retained Free Cash Flow in AIP, moved PS goal-setting to a 3-year cumulative basis, added a relative TSR payout modifier, and reaffirmed no repeat of special grants (including no additional special CEO grants) .
- FY2025 AIP and PS outcomes (below target) reflected alignment with achieved results and shareholder experience .
Compensation Peer Group (used for FY2025 decisions)
Campbell Soup; Church & Dwight; Clorox; Colgate-Palmolive; General Mills; Hershey; Hormel; J.M. Smucker; Kellanova; Keurig Dr Pepper; Kimberly-Clark; Kraft Heinz; McCormick; Mondelēz; Newell Brands; Post Holdings .
Compensation Structure Analysis
- Cash vs equity mix: Significant equity emphasis; for NEOs other than CEO, ~80% of target compensation opportunity is performance-based in FY2025 .
- Shift toward RSUs vs options: No new options since 2016; RSUs and PS dominate LTI; RSUs since 7/19/2023 vest ratably (releases create periodic, not cliff, supply), except specified retention RSUs which cliff vest (e.g., Marberger’s FY2024 retention RSUs vest 3 years from grant) .
- Metric rigor and alignment: AIP emphasizes Adjusted Operating Profit, Net Sales, and Free Cash Flow; PS emphasizes Adjusted EPS and Net Sales with a relative TSR modifier; Clawback in place; pledging/hedging prohibited; double-trigger CoC vesting .
Risk Indicators & Red Flags
- Special awards: FY2024 one-time retention grant to CFO (mix of PS and cliff RSUs) to mitigate retention risk; committee later reaffirmed intent to avoid similar special grants going forward (CEO) and improved disclosures; governance mitigants include clawback and double-trigger CoC vesting .
- No option repricing/backdating without shareholder approval; no excise tax gross-up since FY2012 .
Employment Terms – Additional Notes
- Retirement eligibility considerations and prorated vesting schedules apply under award agreements; award continuation rules for death/disability outlined in proxy tables .
Investment Implications
- Alignment: Marberger holds ~293K shares with total ownership ~10x salary vs a 4x guideline, indicating high alignment; pledging/hedging prohibited; significant unvested PS exposure further links value to multi-year EPS/Net Sales and relative TSR .
- Retention and supply dynamics: FY2024 retention RSUs cliff vest on/around July 2026 (3 years from 7/19/2023), a potential localized supply event; ongoing annual RSUs vest ratably, smoothing selling pressure; options outstanding are limited (69,248) and fully vested by 2026 .
- Pay-for-performance signaling: FY2025 AIP and PS payouts below target (74.3% and 70.1%) align with softer sales/operating profit and weaker TSR, reducing risk of misaligned payouts; FCF emphasis supports deleveraging and shareholder returns .
- Governance: No tax gross-ups, double-trigger CoC, refreshed clawback, and external consultant (FW Cook) oversight support shareholder-friendly practices; 2024 Say‑on‑Pay feedback prompted concrete design changes, lowering future pay controversy risk .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks